---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007359"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:47:03.277769+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks discloses ~$74M exposure to failed Silicon Valley Bank via Zymergen subsidiary

## Summary
- Zymergen subsidiary holds ~$74M (6% of total cash) at Silicon Valley Bank.
- SVB closed and FDIC appointed receiver as of March 10, 2023.
- Company has no other material accounts or credit lines with SVB.
- Cash reference point: $74M based on Dec 31, 2022 balance.

## SEC filing metadata
- accession: 0000950170-23-007359
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000095017023007359/0000950170-23-007359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000095017023007359/dna-20230301.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007359
- JSON: https://secwatch.observer/filing/0000950170-23-007359.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007359.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.